Visual Analogue Scale for Sino-nasal Symptoms Severity Correlates with Sino-nasal Outcome Test 22: Paving the Way for a Simple Outcome Tool of CRS Burden

Overview

Journal Clin Transl Allergy

Publisher Wiley

Specialty Allergy & Immunology

Date 2018 Sep 7

PMID 30186592

Citations 24

Authors

Maria Doulaptsi

Emmanuel Prokopakis

Sven Seys

Benoit Pugin

Brecht Steelant

Peter Hellings

Affiliations

Soon will be listed here.

Abstract

Background: A visual analogue scale (VAS) is a psychometric instrument widely used in the Rhinology field to subjectively quantify patient's symptoms severity. In allergic rhinitis, VAS has been found to correlate well with the allergic rhinitis and its impact on asthma severity classification, as well as with rhinoconjunctivitis quality of life questionnaire. In chronic rhinosinusitis (CRS), total VAS score are often used to classify disease burden into mild, moderate, and severe, with few studies correlating VAS scores with more complex and validated instruments assessing disease-specific burden like Sino-Nasal Outcome Test (SNOT)-22.

Methods: We correlated VAS scores for total and individual sino-nasal symptom with SNOT-22 scores in a randomly selected group of 180 CRS patients. Pearson's rho was selected as a correlation coefficient for analysis.

Results: VAS scores for total nasal symptom score and individual symptoms correlated significantly with SNOT-22, irrespective of VAS based subclasses for sino-nasal, ocular, and bronchial symptoms.

Conclusions: VAS for total sino-nasal symptom severity might be used for assessing disease severity, monitoring the course of the disease, and can be used for treatment decisions and disease burden.

Citing Articles

Pilot Study on the Efficacy of a Novel Questionnaire for Assessing Psychological Health in Patients with Chronic Rhinosinusitis with Nasal Polyps Treated with Biologics.

Masieri S, Cavaliere C, Loperfido A, Begvarfaj E, Ciofalo A, Primerano F Healthcare (Basel). 2025; 13(4).

PMID: 39997308 PMC: 11855081. DOI: 10.3390/healthcare13040433.

Clinical Evidence of the Use of Mepolizumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: A Prospective Observational Study.

Moffa A, Iafrati F, Giorgi L, Nardelli D, Carnuccio L, Baptista P Healthcare (Basel). 2025; 13(4).

PMID: 39997294 PMC: 11855528. DOI: 10.3390/healthcare13040419.

Content Validity of Patient-Reported Outcome Measures Developed for Assessing Disease-Specific Quality of Life in Children With Sinonasal Disease: A Systematic Review.

Williams I, Rotimi O, Burrows L, Navaratnam A, Tan N Int Forum Allergy Rhinol. 2025; 15(3):317-327.

PMID: 39968608 PMC: 11872780. DOI: 10.1002/alr.23539.

Patient-reported disease control versus overall symptom severity as global metrics of chronic rhinosinusitis disease status.

Cotter R, Garcia J, Alsayed A, Schneider S, Liu D, Eckl-Dorna J Int Forum Allergy Rhinol. 2024; 15(1):27-35.

PMID: 39269197 PMC: 11697220. DOI: 10.1002/alr.23435.

Real-Life Evidence of Mepolizumab Treatment in Chronic Rhinosinusitis with Nasal Polyps: A Multicentric Study.

Cavaliere C, Loperfido A, Ciofalo A, Di Michele L, Begvarfaj E, Bellocchi G J Clin Med. 2024; 13(12).

PMID: 38930104 PMC: 11204559. DOI: 10.3390/jcm13123575.

References

Bousquet J, Caimmi D, Bedbrook A, Bewick M, Hellings P, Devillier P . Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy. 2017; 72(6):857-865. DOI: 10.1111/all.13125. View

Fokkens W, Lund V, Mullol J, Bachert C, Alobid I, Baroody F . EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012; 50(1):1-12. DOI: 10.4193/Rhino12.000. View

Klimek L, Bergmann K, Biedermann T, Bousquet J, Hellings P, Jung K . Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of.... Allergo J Int. 2017; 26(1):16-24. PMC: 5288410. DOI: 10.1007/s40629-016-0006-7. View

Wabnitz D, Nair S, Wormald P . Correlation between preoperative symptom scores, quality-of-life questionnaires, and staging with computed tomography in patients with chronic rhinosinusitis. Am J Rhinol. 2005; 19(1):91-6. View

Hellings P, Akdis C, Bachert C, Bousquet J, Pugin B, Adriaensen G . EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis. Rhinology. 2017; 55(3):202-210. DOI: 10.4193/Rhin17.028. View

Hopkins C, Browne J, Slack R, Lund V, Brown P . The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?. Otolaryngol Head Neck Surg. 2007; 137(4):555-61. DOI: 10.1016/j.otohns.2007.02.004. View

Orlandi R, Kingdom T, Hwang P, Smith T, Alt J, Baroody F . International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 2016; 6 Suppl 1:S22-209. DOI: 10.1002/alr.21695. View

Hastan D, Fokkens W, Bachert C, Newson R, Bislimovska J, Bockelbrink A . Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy. 2011; 66(9):1216-23. DOI: 10.1111/j.1398-9995.2011.02646.x. View

Hopkins C, Gillett S, Slack R, Lund V, Browne J . Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009; 34(5):447-54. DOI: 10.1111/j.1749-4486.2009.01995.x. View

10.

Bousquet J, Schunemann H, Fonseca J, Samolinski B, Bachert C, Canonica G . MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy. 2015; 70(11):1372-92. DOI: 10.1111/all.12686. View

11.

Brozek J, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S . Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017; 140(4):950-958. DOI: 10.1016/j.jaci.2017.03.050. View

12.

Hellings P, Fokkens W, Bachert C, Akdis C, Bieber T, Agache I . Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017; 72(9):1297-1305. DOI: 10.1111/all.13162. View

13.

Benninger M, Senior B . The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head Neck Surg. 1997; 123(11):1175-9. DOI: 10.1001/archotol.1997.01900110025004. View

14.

Toma S, Hopkins C . Stratification of SNOT-22 scores into mild, moderate or severe and relationship with other subjective instruments. Rhinology. 2016; 54(2):129-33. DOI: 10.4193/Rhino15.072. View

15.

Seys S, Bousquet J, Bachert C, Fokkens W, Agache I, Bernal-Sprekelsen M . mySinusitisCoach: patient empowerment in chronic rhinosinusitis using mobile technology. Rhinology. 2018; 56(3):209-215. DOI: 10.4193/Rhin17.253. View

16.

van der Veen J, Seys S, Timmermans M, Levie P, Jorissen M, Fokkens W . Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre. Allergy. 2016; 72(2):282-290. PMC: 5248621. DOI: 10.1111/all.12983. View

17.

Hamilos D . Chronic rhinosinusitis: epidemiology and medical management. J Allergy Clin Immunol. 2011; 128(4):693-707. DOI: 10.1016/j.jaci.2011.08.004. View

18.

Caimmi D, Baiz N, Tanno L, Demoly P, Arnavielhe S, Murray R . Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control. Clin Exp Allergy. 2017; 47(12):1526-1533. DOI: 10.1111/cea.13025. View

19.

Piccirillo J, Merritt Jr M, Richards M . Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg. 2002; 126(1):41-7. DOI: 10.1067/mhn.2002.121022. View

20.

Prokopakis E, Vlastos I, Ferguson B, Scadding G, Kawauchi H, Georgalas C . SCUAD and chronic rhinosinusitis. Reinforcing hypothesis driven research in difficult cases. Rhinology. 2014; 52(1):3-8. DOI: 10.4193/Rhino13.049. View